[go: up one dir, main page]

GB9416084D0 - Lactams - Google Patents

Lactams

Info

Publication number
GB9416084D0
GB9416084D0 GB9416084A GB9416084A GB9416084D0 GB 9416084 D0 GB9416084 D0 GB 9416084D0 GB 9416084 A GB9416084 A GB 9416084A GB 9416084 A GB9416084 A GB 9416084A GB 9416084 D0 GB9416084 D0 GB 9416084D0
Authority
GB
United Kingdom
Prior art keywords
lactams
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB9416084A
Other languages
English (en)
Inventor
Alexander Roderick Mackenzie
Alan Patrick Marchington
Sandra Dora Meadows
Donald Stuart Middleton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd Great Britain
Original Assignee
Pfizer Ltd Great Britain
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd Great Britain filed Critical Pfizer Ltd Great Britain
Priority to GB9416084A priority Critical patent/GB9416084D0/en
Priority to GB9417898A priority patent/GB9417898D0/en
Publication of GB9416084D0 publication Critical patent/GB9416084D0/en
Priority to TW084107375A priority patent/TW432061B/zh
Priority to PT95929036T priority patent/PT775132E/pt
Priority to PL95318534A priority patent/PL183180B1/pl
Priority to DE69520502T priority patent/DE69520502T2/de
Priority to CA002197086A priority patent/CA2197086C/en
Priority to HU9700373A priority patent/HUT77771A/hu
Priority to JP50697496A priority patent/JP3159389B2/ja
Priority to PCT/EP1995/003054 priority patent/WO1996005193A1/en
Priority to US08/798,534 priority patent/US5968923A/en
Priority to DK95929036T priority patent/DK0775132T3/da
Priority to NZ291423A priority patent/NZ291423A/en
Priority to RU97104032/04A priority patent/RU2150468C1/ru
Priority to MXPA/A/1997/001006A priority patent/MXPA97001006A/xx
Priority to CN95194416A priority patent/CN1072666C/zh
Priority to ES95929036T priority patent/ES2155894T3/es
Priority to CZ1997381A priority patent/CZ291544B6/cs
Priority to EP95929036A priority patent/EP0775132B1/en
Priority to AT95929036T priority patent/ATE200083T1/de
Priority to AU32549/95A priority patent/AU689303B2/en
Priority to KR1019970700816A priority patent/KR100218626B1/ko
Priority to MYPI95002252A priority patent/MY115975A/en
Priority to IL11482695A priority patent/IL114826A/xx
Priority to PE1995275289A priority patent/PE34696A1/es
Priority to BR9503582A priority patent/BR9503582A/pt
Priority to CO95035201A priority patent/CO4410338A1/es
Priority to TR95/00981A priority patent/TR199500981A2/xx
Priority to FI970523A priority patent/FI970523A/fi
Priority to NO19970566A priority patent/NO311977B1/no
Priority to GR20010400578T priority patent/GR3035726T3/el
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74Oxygen atoms
    • C07D211/76Oxygen atoms attached in position 2 or 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GB9416084A 1994-08-09 1994-08-09 Lactams Pending GB9416084D0 (en)

Priority Applications (31)

Application Number Priority Date Filing Date Title
GB9416084A GB9416084D0 (en) 1994-08-09 1994-08-09 Lactams
GB9417898A GB9417898D0 (en) 1994-08-09 1994-09-06 Lactams
TW084107375A TW432061B (en) 1994-08-09 1995-07-17 Lactams
KR1019970700816A KR100218626B1 (ko) 1994-08-09 1995-07-29 타키키닌 길항물질로서의 (아제티딘-1-일알킬)락탐
MXPA/A/1997/001006A MXPA97001006A (en) 1994-08-09 1995-07-29 Lacta
EP95929036A EP0775132B1 (en) 1994-08-09 1995-07-29 (azetidin-1-ylalkyl)lactams as tachykinin antagonists
DE69520502T DE69520502T2 (de) 1994-08-09 1995-07-29 (azetidinyl-1-ylalkyl)lactame und zwischenprodukte als tachykinin antagonisten
CA002197086A CA2197086C (en) 1994-08-09 1995-07-29 (azetidin-1-ylalkyl)lactams as tachykinin antagonists
HU9700373A HUT77771A (hu) 1994-08-09 1995-07-29 Tachikinin antagonista hatású (azetidin-1-il-alkil)-laktám-származékok
JP50697496A JP3159389B2 (ja) 1994-08-09 1995-07-29 タキキニンアンタゴニストとしての(アゼチジン−1−イルアルキル)
PCT/EP1995/003054 WO1996005193A1 (en) 1994-08-09 1995-07-29 (azetidin-1-ylalkyl)lactams as tachykinin antagonists
US08/798,534 US5968923A (en) 1994-08-09 1995-07-29 (Azetidin-1-ylalkyl) lactams as tachykinin antagonists
DK95929036T DK0775132T3 (da) 1994-08-09 1995-07-29 (Azetidin-1-ylalkyl)lactamer som tachykininantagonister
NZ291423A NZ291423A (en) 1994-08-09 1995-07-29 5-(azetidin-1-ylalkyl)-2-piperidone lactams as tachykinin antagonists and intermediates thereof
RU97104032/04A RU2150468C1 (ru) 1994-08-09 1995-07-29 Производные (азетидин-1-илалкил)лактамов, фармацевтическая композиция на их основе и способ лечения человека, при котором заболевание лечат посредством продуцирования антагонистического действия на тахикинин, действующий в человеческом nк1-, nк2- и nк3-рецепторе или в их сочетании
PT95929036T PT775132E (pt) 1994-08-09 1995-07-29 (azetidin-1-ilalquil)lactamas uteis como antagonistas de taquicinina
CN95194416A CN1072666C (zh) 1994-08-09 1995-07-29 用作速激肽拮抗剂的(氮杂环丁-1-基烷基)内酰胺
ES95929036T ES2155894T3 (es) 1994-08-09 1995-07-29 (azetidin-1-ilalquil)lactamas como antagonistas de la taquicinina.
CZ1997381A CZ291544B6 (cs) 1994-08-09 1995-07-29 (Azetidin-1-ylalkyl)laktamy, jejich použití, meziprodukty pro jejich výrobu a farmaceutické prostředky na jejich bázi
PL95318534A PL183180B1 (pl) 1994-08-09 1995-07-29 Nowe pochodne (azetydyn-1-yloalkilo)laktamów, nowe związki pośrednie i środek farmaceutyczny
AT95929036T ATE200083T1 (de) 1994-08-09 1995-07-29 (azetidinyl-1-ylalkyl)lactame und zwischenprodukte als tachykinin antagonisten
AU32549/95A AU689303B2 (en) 1994-08-09 1995-07-29 (Azetidin-1-ylalkyl)lactams as tachykinin antagonists
MYPI95002252A MY115975A (en) 1994-08-09 1995-08-02 Lactams
IL11482695A IL114826A (en) 1994-08-09 1995-08-03 Azetidinylalkyllactam derivatives processes for their preparation pharmaceutical compositions comprising them and uses thereof
PE1995275289A PE34696A1 (es) 1994-08-09 1995-08-03 Derivado de acetidinilalquil-lactama
BR9503582A BR9503582A (pt) 1994-08-09 1995-08-08 Composto composiçao farmaceutica utilizaçao e método de tratamento de um ser humano
CO95035201A CO4410338A1 (es) 1994-08-09 1995-08-08 DERIVADOS ACETIDINILALQUIL-LACTAMA, PROCEDIMIENTOS PARA LA PREPARACION DE TALES DERIVADOS, INTERMEDIOS USADOS EN LA PREPARACION DE LOS MISMOS y COMPOSICIONES QUE LOS CONTIENEN .
TR95/00981A TR199500981A2 (tr) 1994-08-09 1995-08-09 Laktamlar, bilhassa azetidinilalkillaktam türevleri.
FI970523A FI970523A (fi) 1994-08-09 1997-02-07 (Atsetidin-1-yylialkyyli)laktaamit takykiniiniantagonisteina
NO19970566A NO311977B1 (no) 1994-08-09 1997-02-07 (Azetidin-1-ylalkyl) laktamer som tachykinin-antagonister
GR20010400578T GR3035726T3 (en) 1994-08-09 2001-04-06 (azetidin-1-ylalkyl)lactams as tachykinin antagonists

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9416084A GB9416084D0 (en) 1994-08-09 1994-08-09 Lactams

Publications (1)

Publication Number Publication Date
GB9416084D0 true GB9416084D0 (en) 1994-09-28

Family

ID=10759627

Family Applications (2)

Application Number Title Priority Date Filing Date
GB9416084A Pending GB9416084D0 (en) 1994-08-09 1994-08-09 Lactams
GB9417898A Pending GB9417898D0 (en) 1994-08-09 1994-09-06 Lactams

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB9417898A Pending GB9417898D0 (en) 1994-08-09 1994-09-06 Lactams

Country Status (5)

Country Link
KR (1) KR100218626B1 (ko)
CO (1) CO4410338A1 (ko)
GB (2) GB9416084D0 (ko)
PE (1) PE34696A1 (ko)
PL (1) PL183180B1 (ko)

Also Published As

Publication number Publication date
GB9417898D0 (en) 1994-10-26
KR100218626B1 (ko) 1999-09-01
PL318534A1 (en) 1997-06-23
CO4410338A1 (es) 1997-01-09
KR970704729A (ko) 1997-09-06
PL183180B1 (pl) 2002-05-31
PE34696A1 (es) 1996-10-01

Similar Documents

Publication Publication Date Title
GB9520261D0 (en) Bisresorcinyltriazines
ZA9510554B (en) Substituted 1H-imidazoles
EP0778836A4 (en) 9-SUBSTITUTED ALKYLADENINS
HU9502378D0 (en) Substituted biphenyl-oxazolinones
ZA954095B (en) Substituted 3-phenylpyrazoles
ZA956011B (en) Substituted triazolylmethylphenylnaphthyridones
ZA954546B (en) Substituted 3-phenylpyrazoles
GB9416026D0 (en) Flexigraze
GB9413926D0 (en) Polyamides
ZA951092B (en) Substituted oxazacycloalkenes
GB9421909D0 (en) Headware
GB9416084D0 (en) Lactams
KR0108055Y1 (en) Electrocyclone
GB9403047D0 (en) Top-Tee
GB9522948D0 (en) Lactams
ZA956706B (en) Substituted biphenyloxazolines
SG33624A1 (en) Substituted 1H-imidazoles
GB9403978D0 (en) Aqua-ramp
GB9421601D0 (en) Steer-lok
GB9403117D0 (en) Tap-cap
GB9403498D0 (en) Fixapost
AU124521S (en) Lightfitting
GB9404744D0 (en) Pluggit
GB9405118D0 (en) Puttaline
GB9406415D0 (en) Pedlock